CSG is trading 4.07% up at €18.25 as investors respond to strong first-half 2026 results released August 7, and a new agreement with Poland's Dezamet group announced today.
- First-half 2026 results: Revenue rose 17.2% to €3.25 billion; operating EBIT increased 12.7% to €784 million; order backlog reached €46 billion, exceeding analyst expectations.
- New Agreement: CSG signed an agreement worth over €100 million with Poland's Dezamet group for the supply of 155 mm artillery ammunition components, announced on August 11.
- The full-year outlook was reaffirmed, supporting renewed confidence in growth prospects.